期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Construction and Significance of Directional Expression cDNA Library from Human NB4 Cells
1
作者 陈刚 张王刚 +7 位作者 付杰 曹星梅 赵万红 韩月恒 赵爱志 李福洋 刘新平 药立波 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第1期52-54,58,共4页
Human acute premyeloid leukemia cell cDNA expression library was constructed to screen acute premyeloid leukemia tumor antigen. Total RNA and purified mRNA were extracted from human premyeloid cell line NB4. First and... Human acute premyeloid leukemia cell cDNA expression library was constructed to screen acute premyeloid leukemia tumor antigen. Total RNA and purified mRNA were extracted from human premyeloid cell line NB4. First and second strands of cDNA were synthesized by reverse transcription. After blunting, the cDNA fragments were ligated with EcoR Ⅰ adapters. Then the cDNAs were digested with Xho Ⅰ, and less than 400 bp cDNA fragment was removed by Sephacryl S400 spin column, the remaining were ligated with λZAP vector. The recombinants were packaged in vitro , and a small portion of packaged phage was used to infect E. coli XL1 Blue MRF' for titration. The recombinants were examined by color selection. In order to evaluate the size of cDNA inserts and the diversity of library, the pBK CMV phagemid was excised from the ZAP express vector by using ExAssist helper phage with XLOLR strain, and then the pBK CMV phagemid was digested by Xho Ⅰ and EcoR Ⅰ. The results showed that the NB4 cell line cDNA library consisting of 1.65×10 6 recombinant bacteriophages was constructed with the recombinant ratio of 99.6 %. The average length of the recombinant exogenous inserts was about 1.7 kb. It was concluded that the constructed cDNA library are deserved to screen target clones. 展开更多
关键词 acute premyeloid leukemia NB4 cells cDNA library
下载PDF
实时定量RT-PCR检测急性早幼粒细胞白血病PML/RARα融合基因的临床意义 被引量:2
2
作者 楼瑾 汪明春 +3 位作者 李明 杜新 黄瑞宏 古庆利 《临床血液学杂志》 CAS 2008年第3期250-254,共5页
目的:探讨实时定量RT-PCR方法检测急性早幼粒细胞白血病(APL)PML/RARα融合基因的临床意义。方法:采用实时定量RT-PCR方法,用Taqman探针检测32例初治APL患者的PML/RARα融合基因3种异构体表达水平,并对治疗过程中的20例患者融合基因表... 目的:探讨实时定量RT-PCR方法检测急性早幼粒细胞白血病(APL)PML/RARα融合基因的临床意义。方法:采用实时定量RT-PCR方法,用Taqman探针检测32例初治APL患者的PML/RARα融合基因3种异构体表达水平,并对治疗过程中的20例患者融合基因表达水平进行动态观察。结果:①实时定量RT-PCR的敏感度为101拷贝数/μl,标准品日间差异及日内差异平均变异系数均<5%;②32例PML/RARα融合基因阳性的初治APL患者中,21例为PML/RARα融合基因长型异构体,11例为PML/RARα融合基因短型异构体;③32例初治患者PML/RARα融合基因表达量中位数和x-±s分别为1.44%,(1.29±1.46)%。比较异构体长型及短型标准拷贝数(NCN)中位数和x-±s分别为1.40%,(1.46±1.18)%和1.28%,(1.39±1.51)%,差异无统计学意义P<0.05;④20例治疗后APL患者PML/RARα融合基因表达水平随着临床治疗而改变。结论:①建立了检测APL微小残留病的高敏感性、高特异性的实时定量RT-PCR方法;②32例初治APL患者PML/RARα融合基因长型及短型异构体mRNANCN差异无统计学意义;③PML-RARα融合基因表达水平的变化与临床疾病发展相一致,有助于疗效评价、微小残留病的检测和预后判断。 展开更多
关键词 白血病 早幼粒细胞性 急性 PML/RARΑ融合基因 实时荧光定量PCR技术 标准化拷贝数 微小残留病
下载PDF
初治APL患者PML/RARα融合基因表达
3
作者 楼瑾 汪明春 +3 位作者 杜新 李明 陶小梅 黄瑞宏 《中国热带医学》 CAS 2009年第2期260-262,共3页
目的检测初治急性早幼粒细胞白血病(APL)患者PML/RARα融合基因异构体类型及表达水平,建立检测微小残留病的标准拷贝数基线。方法应用实时定量RT-PCR方法,采用Taqman探针技术测定32例APL初治患者骨髓标本的PML/RARα融合基因mRNA3种异... 目的检测初治急性早幼粒细胞白血病(APL)患者PML/RARα融合基因异构体类型及表达水平,建立检测微小残留病的标准拷贝数基线。方法应用实时定量RT-PCR方法,采用Taqman探针技术测定32例APL初治患者骨髓标本的PML/RARα融合基因mRNA3种异构体表达水平,并比较异构体之间临床特征有无差异。结果32例PML/RARα融合基因阳性的APL初治患者中21例为PML/RARα融合基因长型异构体,11例为融合基因短型异构体,初治患者融合基因表达量中位数为1.44%(1.29%±1.46%)。长型及短型异构体标准拷贝数(normalized copy number,NCN)中位数分别为1.40%(1.46%±1.18%)和1.28%(1.39%±1.51%),无明显统计学差异,P<0.05,融合基因长型异构体患者在发病时外周血白细胞总数为6.08±13.21(×109/l)明显低短型患者15.11±20.26(×109/l),P<0.01。结论建立了检测APL微小残留病的高敏感性、高特异性的实时定量RT-PCR方法,对分析治疗过程的病情变化和指导治疗方案具有重要意见。 展开更多
关键词 PML/RARΑ融合基因 急性早幼粒细胞白血病 实时荧光定量PCR
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部